1. Home
  2. QUAD vs CADL Comparison

QUAD vs CADL Comparison

Compare QUAD & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quad Graphics Inc

QUAD

Quad Graphics Inc

N/A

Current Price

$6.52

Market Cap

305.8M

ML Signal

N/A

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$4.99

Market Cap

280.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QUAD
CADL
Founded
1971
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
305.8M
280.3M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
QUAD
CADL
Price
$6.52
$4.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$9.90
$18.50
AVG Volume (30 Days)
246.4K
1.2M
Earning Date
01-01-0001
05-28-2026
Dividend Yield
6.00%
N/A
EPS Growth
150.47
N/A
EPS
0.54
N/A
Revenue
$2,419,900,000.00
$125,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.50
$4.25
52 Week High
$7.54
$9.08

Technical Indicators

Market Signals
Indicator
QUAD
CADL
Relative Strength Index (RSI) 46.16 42.30
Support Level $6.42 $4.48
Resistance Level $6.81 $6.16
Average True Range (ATR) 0.32 0.22
MACD -0.07 0.01
Stochastic Oscillator 14.53 38.76

Price Performance

Historical Comparison
QUAD
CADL

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: